A clinical study of mesoridazine and chlorpromazine in relapsed schizophrenic patients.
D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001772:Blood Cell Count; D001799:Blood Sedimentation; D001806:Blood Urea Nitrogen; D002746:Chlorpromazine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005069:Evaluation Studies as Topic; D005260:Female; D006400:Hematocrit; D006452:Hemoglobinometry; D006801:Humans; D008297:Male; D008653:Mesoridazine / Q000627:therapeutic use*; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*
D010919:Placebos; D008653:Mesoridazine; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D002746:Chlorpromazine